153 related articles for article (PubMed ID: 30369228)
1. [A Case of PT1 Plasmacytoid Variant Bladder Cancer Treated by Bladder Conserving Therapy].
Kimura H; Uemura Y; Megumi Y; Fukuzawa S
Hinyokika Kiyo; 2018 Sep; 64(9):369-372. PubMed ID: 30369228
[TBL] [Abstract][Full Text] [Related]
2. [Distant Metastasis in Patients with Non-Muscle Invasive Bladder Cancer without Local Recurrence : Report of Two Rare Cases].
Kida K; Shimizu Y; Ogawa K; Kanamaru S; Ito N
Hinyokika Kiyo; 2018 Jun; 64(6):271-275. PubMed ID: 30064166
[TBL] [Abstract][Full Text] [Related]
3. [Bladder Rupture during Intravesical BCG Therapy : A Case Report].
Iemura Y; Fukui S; Matsumura Y; Kagebayashi Y; Toyoshima Y; Inoue T; Samma S
Hinyokika Kiyo; 2018 Jan; 64(1):25-28. PubMed ID: 29471601
[TBL] [Abstract][Full Text] [Related]
4. Is restaging transurethral resection necessary in patients with non-muscle invasive bladder cancer and limited lamina propria invasion?
Audenet F; Retinger C; Chien C; Benfante NE; Bochner BH; Donat SM; Herr HW; Dalbagni G
Urol Oncol; 2017 Oct; 35(10):603.e1-603.e5. PubMed ID: 28689694
[TBL] [Abstract][Full Text] [Related]
5. [Two cases of vesical nephrogenic adenoma].
Tsurukawa H; Komura H; Sasaki H; Iuchi H; Tokumitsu M; Saga Y; Yamaguchi S; Hashimoto H; Yachiku S
Hinyokika Kiyo; 2003 May; 49(5):285-90. PubMed ID: 12822459
[TBL] [Abstract][Full Text] [Related]
6. Plasmacytoid transitional cell carcinoma of urinary bladder: a clinicopathologic study of 9 cases.
Ro JY; Shen SS; Lee HI; Hong EK; Lee YH; Cho NH; Jung SJ; Choi YJ; Ayala AG
Am J Surg Pathol; 2008 May; 32(5):752-7. PubMed ID: 18379419
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcomes of second transurethral resection in non-muscle invasive high-grade bladder cancer: a retrospective, multi-institutional, collaborative study.
Kamiya N; Suzuki H; Suyama T; Kobayashi M; Fukasawa S; Sekita N; Mikami K; Nihei N; Naya Y; Ichikawa T
Int J Clin Oncol; 2017 Apr; 22(2):353-358. PubMed ID: 27744487
[TBL] [Abstract][Full Text] [Related]
8. Management of high-risk non-muscle invasive bladder cancer.
Brausi M; Olaru V
Minerva Urol Nefrol; 2012 Dec; 64(4):255-60. PubMed ID: 23288212
[TBL] [Abstract][Full Text] [Related]
9. Plasmacytoid urothelial carcinoma of the bladder: histological and clinical features of 5 cases.
Fritsche HM; Burger M; Denzinger S; Legal W; Goebell PJ; Hartmann A
J Urol; 2008 Nov; 180(5):1923-7. PubMed ID: 18801525
[TBL] [Abstract][Full Text] [Related]
10. Evolution and prognosis of bladder papillomatosis managed by endoscopic resection and endovesical BCG therapy : about 24 cases.
Sallami S; Gammoudi A; Cherni R; Chelly I; Horchani A
Tunis Med; 2013 Oct; 91(10):573-6. PubMed ID: 24281996
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for intravesical recurrence in patients with high-grade T1 bladder cancer in the second TUR era.
Takaoka E; Matsui Y; Inoue T; Miyazaki J; Nakashima M; Kimura T; Oikawa T; Kawai K; Yoshimura K; Habuchi T; Ogawa O; Nishiyama H
Jpn J Clin Oncol; 2013 Apr; 43(4):404-9. PubMed ID: 23444116
[TBL] [Abstract][Full Text] [Related]
12. Oncological outcomes of a single but extensive transurethral resection followed by appropriate intra-vesical instillation therapy for newly diagnosed non-muscle-invasive bladder cancer.
Koie T; Ohyama C; Hosogoe S; Yamamoto H; Imai A; Hatakeyama S; Yoneyama T; Hashimoto Y; Yoneyama T; Tobisawa Y; Mori K
Int Urol Nephrol; 2015 Sep; 47(9):1509-14. PubMed ID: 26149637
[TBL] [Abstract][Full Text] [Related]
13. [Results of BCG in the treatment of pTa and pT1 bladder tumors. Evaluation of a long protocol using 75 mg of Pasteur strain BCG].
Ayed M; Ben Hassine L; Ben Slama R; Chelbi N; Ghozzi S; Drissi H; Jemni M; Chebil M
Prog Urol; 1998 Apr; 8(2):206-10. PubMed ID: 9615929
[TBL] [Abstract][Full Text] [Related]
14. [A case of transitional cell carcinoma with squamous differentiation which developed squamous cell carcinoma in situ in the clinical course].
Sugiura S; Makiyama K; Yokomizo Y; Umemoto S; Miyoshi Y; Nakaigawa N; Ogawa T; Uemurai H; Yao M; Kubota Y; Yamanaka S
Hinyokika Kiyo; 2006 Sep; 52(9):715-8. PubMed ID: 17040058
[TBL] [Abstract][Full Text] [Related]
15. Transition between urothelial carcinoma in situ and non-invasive micropapillary carcinoma as a pivot connection between diverse morphologies of bladder carcinoma: a case report of urothelial carcinoma with villoglandular differentiation.
Tajima S; Koda K
Int J Clin Exp Pathol; 2015; 8(3):3288-93. PubMed ID: 26045854
[TBL] [Abstract][Full Text] [Related]
16. Plasmacytoid urothelial carcinoma of the bladder.
Lopez-Beltran A; Requena MJ; Montironi R; Blanca A; Cheng L
Hum Pathol; 2009 Jul; 40(7):1023-8. PubMed ID: 19297008
[TBL] [Abstract][Full Text] [Related]
17. Feasibility of early intravesical instillation chemotherapy after transurethral resection of the bladder: a prospective evaluation in a consecutive series of 210 cases.
Engeler DS; Wyler S; Neyer M; Hobi C; Müller J; Schmid HP
Scand J Urol Nephrol; 2008; 42(6):522-7. PubMed ID: 18609290
[TBL] [Abstract][Full Text] [Related]
18. Update on the Dutch Cooperative Trial: mitomycin versus bacillus Calmette-Guérin-Tice versus bacillus Calmette-Guérin RIVM in the treatment of patients with pTA-pT1 papillary carcinoma and carcinoma in situ of the urinary bladder. Dutch South East Cooperative Urological Group.
Witjes WP; Witjes JA; Oosterhof GO; Debruyne MJ
Semin Urol Oncol; 1996 Feb; 14(1 Suppl 1):10-6. PubMed ID: 8727805
[TBL] [Abstract][Full Text] [Related]
19. Langerhans cell histiocytosis of the urinary bladder in a patient with bladder cancer previously treated with intravesical Bacillus Calmette-Guérin therapy.
Numakura S; Morikawa T; Ushiku T; Toyoshima T; Fukayama M
Pathol Res Pract; 2014 Feb; 210(2):123-6. PubMed ID: 24332601
[TBL] [Abstract][Full Text] [Related]
20. Histological changes due to intravesical instillation of mitomycin C.
Castillo OA; Landerer E; Feria-Flores M; Vidal-Mora I; Franco C
Arch Esp Urol; 2012 Jun; 65(5):578-82; discussion 582. PubMed ID: 22732786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
